Do early postnatal body weight changes contribute to neonatal morbidities in the extremely low birth weight infants

R Verma1, S Shibly2, H Fang3

  • 1Nassau County University Hospital, East Meadow, NY, USA.

Insights

Early postnatal weight changes in extremely low birth weight infants are linked to reduced risks of serious neonatal morbidities like PDA, BPD, and IVH. These findings highlight the importance of monitoring weight trends in high-risk preterm infants.

Area of Science:

  • Neonatalogy
  • Perinatal Medicine
  • Pediatric Critical Care

Background:

  • Early postnatal weight changes (Δbw) in extremely low birth weight (ELBW) infants are not well understood concerning fluid metabolism morbidities.
  • ELBW infants (<1000g) face the highest incidence of these complications.

Purpose of the Study:

  • To investigate the association between early postnatal weight changes and neonatal morbidities in ELBW infants.
  • To analyze the relationship between daily weight changes (DΔ bw) and maximum weight loss (MΔ bw) with specific morbidities.

Main Methods:

  • Observational study analyzing daily weight changes (DΔ bw) and maximum weight loss (MΔ bw).
  • Evaluated associations with oxygen dependence at day 28 (BPD28), patent ductus arteriosus (PDA), and intraventricular-periventricular hemorrhage (IVH).
  • Used Pearson's correlation and multivariate logistic regressions, controlling for gestational age (GA) and antenatal steroids (ANS).

Main Results:

  • Daily weight changes (DΔ bw) correlated inversely with GA in the first week.
  • DΔ bw was associated with reduced risk of BPD28, PDA, and IVH, independent of GA.
  • Maximum weight loss (MΔ bw) showed a direct correlation with BPD28, which diminished after controlling for GA.
  • Antenatal steroids (ANS) decreased DΔ bw.

Conclusions:

  • Daily weight changes (DΔ bw) demonstrate a protective effect against PDA, BPD28, and IVH in ELBW infants, irrespective of gestational age.
  • The impact of maximum weight loss (MΔ bw) on bronchopulmonary dysplasia (BPD) is influenced by infant maturation.
  • Antenatal steroid administration is linked to reduced daily weight changes and inverse correlation with gestational age in the first week of life.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...